• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过灵敏的酶联免疫吸附测定法定量检测人补体的C3d裂解产物。

Quantification of the C3d split products of human complement by a sensitive enzyme-linked immunosorbent assay.

作者信息

Mollnes T E

出版信息

Scand J Immunol. 1985 Jun;21(6):607-13. doi: 10.1111/j.1365-3083.1985.tb01851.x.

DOI:10.1111/j.1365-3083.1985.tb01851.x
PMID:3895396
Abstract

A double-antibody biotin-avidin enzyme-linked immunosorbent assay (ELISA) for quantification of the C3d split products is described. Polyethylene glycol 6000 was used to precipitate large C3 molecules, and the C3d-containing supernatant was used in the assay. C3d was measured in ethylenediaminetetraacetic acid plasma from 40 healthy blood donors, and the normal range was defined. Twenty-two patients were tested, and 12 of these had increased levels of C3d. No correlation was observed between total C3 and C3d in these patients. There was a close correlation between C3d measured by this method and by the double-decker rocket immunoelectrophoresis method. The C3d ELISA method is very sensitive, easy to perform, and time-saving and economical compared with most C3d methods already described. A procedure to define the lower detection limit and examine the reliability of an ELISA method in general is discussed.

摘要

描述了一种用于定量C3d裂解产物的双抗体生物素-抗生物素蛋白酶联免疫吸附测定(ELISA)。使用聚乙二醇6000沉淀大的C3分子,并将含C3d的上清液用于该测定。对40名健康献血者的乙二胺四乙酸血浆中的C3d进行了测量,并确定了正常范围。对22名患者进行了检测,其中12名患者的C3d水平升高。在这些患者中,未观察到总C3与C3d之间的相关性。通过该方法测量的C3d与双层火箭免疫电泳法测量的C3d之间存在密切相关性。与已描述的大多数C3d方法相比,C3d ELISA方法非常灵敏、易于操作,且省时经济。讨论了确定下限检测限和一般检查ELISA方法可靠性的程序。

相似文献

1
Quantification of the C3d split products of human complement by a sensitive enzyme-linked immunosorbent assay.通过灵敏的酶联免疫吸附测定法定量检测人补体的C3d裂解产物。
Scand J Immunol. 1985 Jun;21(6):607-13. doi: 10.1111/j.1365-3083.1985.tb01851.x.
2
Comparative study of assays detecting complement activation. Complement-split product C3d (rocket immuno-electrophoresis) and C3d neodeterminants (ELISA).检测补体激活的分析方法的比较研究。补体裂解产物C3d(火箭免疫电泳法)和C3d新抗原决定簇(酶联免疫吸附测定法)。
Scand J Clin Lab Invest. 1990 Jun;50(4):389-93. doi: 10.3109/00365519009091596.
3
Measurement of C3 conversion by ELISA estimation of neo-determinants on the C3d moiety.通过酶联免疫吸附测定法(ELISA)评估C3d部分上新决定簇来测量C3转化。
J Immunol Methods. 1986 Nov 20;94(1-2):1-6. doi: 10.1016/0022-1759(86)90207-3.
4
Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma.用于直接定量血浆中具有C3d特异性的补体C3裂解产物的双层火箭免疫电泳法。
J Immunol Methods. 1981;44(1):63-71. doi: 10.1016/0022-1759(81)90107-1.
5
Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3.酶联免疫吸附测定法中对活化的人补体因子C3上表达的C3新表位的定量分析。
Scand J Immunol. 1988 Mar;27(3):329-35. doi: 10.1111/j.1365-3083.1988.tb02354.x.
6
Quantification of C3d in biological fluids by an enzyme-linked immunosorbent assay.
J Immunol Methods. 1987 Nov 23;104(1-2):51-6. doi: 10.1016/0022-1759(87)90486-8.
7
The third complement factor (C3) and its in vivo cleavage products: interaction with lectins and precipitation with polyethylene glycol.第三种补体因子(C3)及其体内裂解产物:与凝集素的相互作用以及用聚乙二醇沉淀
J Immunol Methods. 1984 Jan 20;66(1):113-8. doi: 10.1016/0022-1759(84)90254-0.
8
Plasma C3d/C3 quotient as a parameter for in vivo complement activation.
J Immunol Methods. 1984 Nov 16;74(1):87-91. doi: 10.1016/0022-1759(84)90370-3.
9
Specificities of monoclonal antibodies against the complement C3d split product.
Complement Inflamm. 1990;7(1):18-29. doi: 10.1159/000463123.
10
Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis.通过火箭免疫电泳法检测补体C3裂解产物C3d
J Immunol Methods. 1982;48(1):97-108. doi: 10.1016/0022-1759(82)90214-9.

引用本文的文献

1
Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.自身免疫性疾病中免疫沉淀预防缺陷与C4A*Q0无关。
Clin Exp Immunol. 2005 Jun;140(3):572-9. doi: 10.1111/j.1365-2249.2005.02794.x.
2
Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leucocytes: functional relevance and role in inflammation.细胞凋亡与多形核白细胞上补体调节分子、黏附分子及其他受体的表达降低有关:功能相关性及在炎症中的作用。
Immunology. 1995 Dec;86(4):651-60.
3
Evaluation of in vivo immune complex formation and complement activation in patients receiving intravenous streptokinase.
接受静脉注射链激酶治疗的患者体内免疫复合物形成及补体激活的评估。
Clin Exp Immunol. 1993 Nov;94(2):286-90. doi: 10.1111/j.1365-2249.1993.tb03445.x.
4
Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.肾炎因子对体内外补体C3及补体终末途径的影响。
Clin Exp Immunol. 1986 Jul;65(1):73-9.
5
Measurement of terminal complement complexes in rheumatoid arthritis.类风湿关节炎中终末补体复合物的测定。
Clin Exp Immunol. 1988 Sep;73(3):473-8.
6
Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?综述:临床免疫学实验室中补体激活的评估:是否到了重新评估的时候?
J Clin Pathol. 1989 Oct;42(10):1018-25. doi: 10.1136/jcp.42.10.1018.